יחס מחיר לרווח Alterity Therapeutics Ltd. (ATHE)

Alterity Therapeutics (ATHE) automates the synthesis of Parkinson's disease medications using algorithms while ensuring physicians maintain control over patient status. The business is currently focused on completing molecule trials for the therapy of rare pathologies before onboarding partners. This price chart on GURU.Markets, where the indicator stands at -2.40, complements data regarding the company's sustainable approach to bioethics and the minimization of chemical waste.

Alterity Therapeutics (ATHE) focuses on developing drugs for neurodegenerative pathologies, operating on investments without stable operating income. Under these conditions, the company's historical P/E ratio reflects the relationship between market value and net income, helping to distinguish an undervalued asset from a "value trap" and avoid freezing capital in a loss-making business through an analysis of payback dynamics.